Search

Your search keyword '"Levodopa chemical synthesis"' showing total 35 results

Search Constraints

Start Over You searched for: Descriptor "Levodopa chemical synthesis" Remove constraint Descriptor: "Levodopa chemical synthesis"
35 results on '"Levodopa chemical synthesis"'

Search Results

1. Synthesis, characterization and in-vitro prolonged release of L-DOPA using a novel amphiphilic hydrogel based on sodium alginate-polypyrrole.

2. L-Dopa release from mesoporous silica nanoparticles engineered through the concept of drug-structure-directing agents for Parkinson's disease.

3. Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents.

4. Preparation of levodopa-loaded crystalsomes through thermally induced crystallization reverses functional deficits in Parkinsonian mice.

5. l-Dopa and dopamine conjugated naphthalenediimides modulate amyloid β toxicity.

6. The Design and Evaluation of an l-Dopa-Lazabemide Prodrug for the Treatment of Parkinson's Disease.

7. Synthesis and antiproliferative activity of two diastereomeric lignan amides serving as dimeric caffeic acid-l-DOPA hybrids.

8. Current Advances in L-DOPA and DOPA-Peptidomimetics: Chemistry, Applications and Biological Activity.

9. Classics in chemical neuroscience: levodopa.

10. Design, synthesis and biological evaluation of peptide derivatives of L-dopa as anti-parkinsonian agents.

11. L-Dopa synthesis catalyzed by tyrosinase immobilized in poly(ethyleneoxide) conducting polymers.

12. A study on the electrochemical synthesis of L-DOPA using oxidoreductase enzymes: optimization of an electrochemical process.

13. Molecular mechanism underlying the cerebral effect of Gly-Pro-Glu tripeptide bound to L-dopa in a Parkinson's animal model.

14. Electroenzymatic synthesis of l-DOPA.

15. Synthesis of dopamine and L-DOPA-alpha-glycosides by reaction with cyclomaltohexaose catalyzed by cyclomaltodextrin glucanyltransferase.

16. Preparation of levodopa-2, 6-dimethyl-beta-cyclodextrin inclusion by saturation solution process.

17. Novel L-Dopa and dopamine prodrugs containing a 2-phenyl-imidazopyridine moiety.

18. Synthesis and study of L-dopa-glutathione codrugs as new anti-Parkinson agents with free radical scavenging properties.

19. Glycosyl derivatives of dopamine and L-dopa as anti-Parkinson prodrugs: synthesis, pharmacological activity and in vitro stability studies.

20. Asymmetric hydrogenations (Nobel lecture).

21. Dimeric L-dopa derivatives as potential prodrugs.

23. Synthesis and evaluation of radioiodinated 6-iodo-L-DOPA as a cerebral L-amino acid transport marker.

25. Synthesis of no-carrier-added L- and D-[1-11C]-DOPA.

26. [Methods of obtaining L forms of tyrosine and 3,4-dihydroxyphenylalanine (a review)].

28. Increase in melanin formation and promotion of cytotoxicity in cultured melanoma cells caused by phosphorylated isomers of L-dopa.

29. A new potential prodrug to improve the duration of L-dopa: L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine.

31. Multivariate statistical analysis of L-dopa esters as potential anti-parkinsonian prodrugs.

32. Improved delivery through biological membranes. 4. Prodrugs of L-dopa.

33. Aromatic radiofluorination with [18F]fluorine gas: 6-[18F]fluoro-L-dopa.

34. Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity.

Catalog

Books, media, physical & digital resources